A novel intergenic region (chr2: 30,193,816)-ALK fusion shows sensitivity to Alectinib in lung adenocarcinoma

被引：0
|
作者：
Ting Wang
Ge Du
Man Niu
Rui Liu
机构：
[1] Xi’an People’s Hospital (Xi’an No.4 Hospital),Department of Respiratory Medicine
[2] Beijing Rehabilitation Hospital Affiliated to Capital Medical University,Department of Rehabilitation Center for Elderly
[3] Xi’an People’s Hospital (Xi’an No.4 Hospital),Department of Pathology Medicine
来源：
BMC Pulmonary Medicine | / 23卷
关键词：
Anaplastic lymphoma kinase; Intergenic; Lung cancer; Case report;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] OFCC1-ALK (Ointergenic: A20): A novel OFCC1 intergenic region-ALK fusion identified from a lung adenocarcinoma patient
    Zhai, Xiaoqian
    Wu, Qiang
    Zeng, Zhen
    Suo, Jing
    Lin, Feng
    Zhou, Qinghua
    [J]. LUNG CANCER, 2021, 153 : 171 - 173
  • [22] A Novel LOC101927967 Intergenic Region ALK Fusion Identified by NGS and Validated by IHC and FISH in a Patient with Early Stage Adenocarcinoma of Lung
    Jia, Xiaojing
    He, Qianru
    Xing, Xiaodan
    Yang, Yanming
    Ma, Yan
    [J]. ONCOTARGETS AND THERAPY, 2022, 15 : 251 - 254
  • [23] Novel-Acquired KANK1-ALK Fusion in An Advanced Lung Adenocarcinoma Responds to Alectinib: A Case Report
    Tang, Q.
    Xu, S.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S673 - S674
  • [24] Case report: Novel junctional sarcoplasmic reticulum protein 1 intergenic region-anaplastic lymphoma kinase fusion in a patient with lung adenocarcinoma responds to alectinib
    Xue, Feng
    Xu, Shengyuan
    Jiang, Cailing
    Kang, Mafei
    Usman, Muhammad
    Zhu, Lin
    [J]. FRONTIERS IN ONCOLOGY, 2022, 12
  • [25] High efficacy of alectinib in a patient with advanced lung adenocarcinoma with 2 rare ALK fusion sites: a case report
    Li, Yan
    Duan, Peng
    Guan, Yan
    Chen, Qing
    Grenda, Anna
    Christopoulos, Petros
    Denis, Marc G.
    Guo, Qisen
    [J]. TRANSLATIONAL LUNG CANCER RESEARCH, 2022, 11 (01) : 100 - 110
  • [26] Concomitance of a novel RMDN2-ALK fusion and an EML4-ALK fusion in a lung adenocarcinoma
    Jiang, Liqun
    Chen, Suping
    Stinnett, Victoria
    Haley, Lisa
    Morsberger, Laura
    Shane, Alison
    Hardy, Melanie
    Smith, Kirstin
    Gocke, Christopher D.
    Lin, Ming-Tseh
    Zhou, Ying S.
    [J]. CANCER GENETICS, 2021, 258 : 18 - 22
  • [27] TMED2-ALK, a Novel ALK Fusion Gene Identified in a Patient With Lung Adenocarcinoma
    Mao, Weijun
    Chen, Ruo
    Zhang, Junling
    Zheng, Mingfeng
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2020, 15 (03) : E37 - E39
  • [28] A Novel Intergenic Region between CENPA and DPYSL5-ALK Exon 20 Fusion Variant Responding to Crizotinib Treatment in a Patient with Lung Adenocarcinoma
    Fei, Xiaodong
    Zhu, Liqun
    Zhou, Hongxuan
    Qi, Chuang
    Wang, Chun
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (09) : E191 - E193
  • [29] Coexistence of a novel NBEA-ALK, EML4-ALK double-fusion in a lung adenocarcinoma patient and response to alectinib: A case report
    Liang, Qi
    Xu, Huanhuan
    Liu, Yiqian
    Zhang, Weiming
    Sun, Chongqi
    Hu, Meng
    Zhu, Yizhi
    Tan, Shanyue
    Xu, Xian
    Wang, Sumeng
    Liu, Lingxiang
    [J]. LUNG CANCER, 2021, 162 : 86 - 89
  • [30] Coexistence of a novel intergenic (between CHST2 and SLC9A9)-ALK, TNIK-ALK double-fusion in resected lung adenocarcinoma
    Liu, Zhenkun
    Huang, Kaili
    Wu, Qiang
    Zhou, Qinghua
    [J]. ASIAN JOURNAL OF SURGERY, 2024, 47 (03) : 1505 - 1507
12345